SEC Form 4 · accession 0001209191-18-018504
Fulgent Genetics, Inc. · FLGT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Kim
Officer — CFO and Treasurer
Period of report
Mar 8, 2018
Accepted (ET)
Mar 9, 2018 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674930
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 8, 2018 | S | 1,628 | $3.76 | D | 385,401 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016.
- F2The shares were sold in multiple transactions at prices ranging from $3.75 to $3.81, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.